Courtesy of The Journal Record
OKLAHOMA CITY – The StartOK Accelerator Fund recently made a $270,000 investment in Oklahoma City-based Moleculera Labs.
Moleculera Labs is a life sciences company developing a test for children suffering from neurologic disorders associated with autoimmune conditions.
The StartOK Fund is managed by i2E.
The i2E investment closed a $540,000 financing round with co-investors that included SeedStep Angels and other out-of-state investors.
Moleculera Labs’ intellectual property is based on the work of Madeleine Cunningham and licensed from the University of Oklahoma.
The StartOK Fund is part of the $13.1 million Accelerate Oklahoma! initiative created by i2E in partnership with the Oklahoma Department of Commerce and the U.S. Treasury State Small Business Credit Initiative. i2E manages three funds under the Accelerate Oklahoma! program, including the GrowOK Fund and the OK Angel Sidecar Fund.
Craig Shimasaki is co-founder and CEO of Moleculera Labs. Cunningham is co-founder and chief scientific officer. – Staff report
Click here to read the article at the Journal Record website.
